VAPB and cerebral infarction: The results show that the PI3K activator can partially reverse the aggravation of injury in CIRI mice induced by VAPB or PTPIP51 reduction, which is manifested by attenuating oxidative stress and autophagy, reducing cerebral infarction volume and improving neurological function.